China Meheco Group 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 


«12...190191192193194195196197198199200...212213»
  • ||||||||||  Paxlovid (nirmatrelvir and ritonavir) / Pfizer
    ¿Paxlovid (Pfizer)? (Twitter) -  Jan 14, 2022   
  • ||||||||||  Paxlovid (nirmatrelvir and ritonavir) / Pfizer
    Paxlovid? (Twitter) -  Jan 14, 2022   
  • ||||||||||  Actemra IV (tocilizumab) / Roche, JW Pharma
    Review, Journal:  The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic. (Pubmed Central) -  Jan 14, 2022   
    Several drugs have been identified that can fit this potential role by targeting different stages of COVID-19 including baricitinib, molnupiravir and PF-07321332/ritonavir and also the combination of deferiprone with N-acetylcysteine for inhibiting the vicious circle of oxidative stress toxicity and endothelial cell damage. Most of these drugs are expected to be effective against all the SARS-CoV-2 variants including Omicron (B.1.1.529) and also the associated COVID-19 complications.